SmHDM-2p58, Smp_194860 (54-85)

General Information


DRACP ID  DRACP03831

Peptide Name   SmHDM-2p58, Smp_194860 (54-85)

Sequence  IRKYLEEDNLGEKLAAVVSIYVKRLNKRLDMR

Sequence Length  32

UniProt ID  G4V7C7 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antiparasitic



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C170H290N50O48S

Absent amino acids  CFHPQTW

Common amino acids  L

Mass  438767

Pl  10.23

Basic residues  8

Acidic residues  5

Hydrophobic residues  12

Net charge  3

Boman Index  -8324

Hydrophobicity  -49.38

Aliphatic Index  118.75

Half Life 
  Mammalian: 20 hour
  Yeast: 30 min
  E.coli: >10 hour

Extinction Coefficient cystines  2980

Absorbance 280nm  96.13

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23875042

Title  Cathelicidin-like helminth defence molecules (HDMs): absence of cytotoxic, anti-microbial and anti-protozoan activities imply a specific adaptation to immune modulation

Doi Not available

Year  2013

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  13423

DRACP is developed by Dr.Zheng's team.